載入...
Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes
BACKGROUND: Overweight or obesity contributes to the development of type 2 diabetes mellitus (T2DM) and increases cardiovascular risk. Exenatide, a glucagon-like peptide-1 receptor agonist, significantly reduces glycated hemoglobin (A1C) and body weight and improves cardiovascular risk markers in pa...
Na minha lista:
| 發表在: | Cardiovasc Diabetol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324846/ https://ncbi.nlm.nih.gov/pubmed/25645567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0171-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|